BioNxt Solutions IncCanadian Securities Exchange:BNXTView on OTC Pink - Current Information
- LAST PRICE0.2400
- TODAY'S CHANGE (%)0.0050 (2.1277%)
- Bid / Lots0.2200/ 50
- Ask / Lots0.2400/ 28
- Open / Previous Close0.2250 / 0.2350
- Day Range
- 52 Week Range
- Volume46,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BNXT |
|---|---|---|
| 09:32 ET | 3000 | 0.24 |
| 12:46 ET | 500 | 0.24 |
| 12:57 ET | 15000 | 0.24 |
| 04:00 ET | 27500 | 0.24 |
Oct 29, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioNxt Solutions Inc | 26.6M | -3.9x | --- |
Pharmather Holdings Ltd | 19.0M | -9.0x | --- |
Devonian Health Group Inc | 19.3M | -6.0x | --- |
Kane Biotech Inc | 13.8M | -2.5x | --- |
Cytophage Technologies Ltd | 13.5M | -0.8x | --- |
Preveceutical Medical Inc | 10.8M | -8.5x | --- |
Company Information
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany. The Company is also focused on regulatory approval and commercialization of medical products for European markets. Its diagnostic products include COVID-19 PCR Diagnostic Kit, Peri-Implantitis Oral Biosensor, and H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors. Its subsidiaries include XPhyto Laboratories Inc., Bunker Pflanzenextrakte GmbH, Vektor Pharma TF GmbH, BioNxt Europe GmbH, and 3a-diagnostics GmbH, among others.
Contact Information
- Headquarters
- Suite 270 - 1820 Fir StreetVANCOUVER, BC, Canada V6J 3B1
- Phone
- 780-818-6422
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $26.6M |
|---|---|
Revenue (TTM) | $30.7K |
Shares Outstanding | 113.4M |
BioNxt Solutions Inc does not pay a dividend. | |
Beta | 0.59 |
EPS | $-0.06 |
Book Value | $-0.05 |
P/E Ratio | -3.9x |
Price/Sales (TTM) | 869.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -17,311.55% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
